ScienceofPD Profile Banner
The Science of Parkinson's Profile
The Science of Parkinson's

@ScienceofPD

Followers
11K
Following
10K
Media
13K
Statuses
24K

Personal account of the Director of Research at @CureParkinsonsT - All views my own - Kiwi - Kia kaha - 侘寂

London, England
Joined January 2016
Don't wanna be here? Send us removal request.
@ScienceofPD
The Science of Parkinson's
7 days
RT @CureParkinsonsT: We are seeking to progress research involving combination therapies as a potential method for Parkinson’s progression.….
0
4
0
@ScienceofPD
The Science of Parkinson's
7 days
Told ya!. "@CureParkinsonsT will be opening a £2 million funding call in October 2025 to encourage the testing of combination therapies for #Parkinsons". Preclinical & clinical projects. DM me if you have any questions .
Tweet card summary image
cureparkinsons.org.uk
As part of our research strategy, Cure Parkinson’s is seeking to progress research involving combination therapies as a potential method for targeting
0
2
4
@grok
Grok
1 day
Join millions who have switched to Grok.
21
21
171
@ScienceofPD
The Science of Parkinson's
11 days
The Science of #Parkinsons will be off-line for the next two weeks - behave yourselves!
Tweet media one
1
0
13
@ScienceofPD
The Science of Parkinson's
11 days
New research from @Basak94Bishal & @ErikaHolzbaur reports the identification of a Mitophagic Stress Response ("MitoSR" - mmm, catchy!) activated by mitochondrial damage in neurons & operating in parallel to canonical Pink1/Parkin-dependent mitophagy.
Tweet media one
0
3
12
@ScienceofPD
The Science of Parkinson's
11 days
LAG3 again!.Researchers develop 2 immunoglobulin-like domains "derived from α-syn receptors, the D1 domain of lymphocyte-activation gene 3 & the V domain of advanced glycation end-products (vRAGE)" that blocks cell surface binding of α-syn fibrils.
Tweet media one
0
2
9
@ScienceofPD
The Science of Parkinson's
12 days
More preclinical data supporting the repurposing of montelukast for #Parkinsons; The leukotriene receptor antagonist improved motor function &⬇️the brain uptake of [18F]GSK ("indicating resynchronization of regional microglial activity") in A53T male mice.
Tweet media one
0
3
16
@ScienceofPD
The Science of Parkinson's
12 days
Researchers report that expression of human A53T alpha-synuclein without endogenous rat alpha-synuclein fails to elicit #Parkinsons-related phenotypes in a novel humanized rat model.
Tweet media one
Tweet media two
Tweet media three
1
0
2
@ScienceofPD
The Science of Parkinson's
12 days
Bioinformatics analysis across GEO datasets identifies biomarkers (NDRG1, DLD, & CIRBP) & mechanisms of action associated with endoplasmic reticulum stress & ferroptosis in #Parkinsons.
Tweet media one
Tweet media two
Tweet media three
0
0
1
@ScienceofPD
The Science of Parkinson's
12 days
Dopamine neuron-specific conditional knockout of mitochondrial transcription factor A (TFAM) in mice=progressive motor deficits, α-synuclein accumulation, dysregulated inter-organelle communication, & neuronal loss in the substantia nigra pars compacta.
Tweet media one
0
0
3
@ScienceofPD
The Science of Parkinson's
12 days
"No correlation between pS129 α-syn & synSAA outcome, indicating that soluble pS129 α-syn in CSF & plasma does not reflect presence of synucleinopathy. Interestingly, pS129 α-syn & other α-syn forms were signif.⬆️in #Alzheimers" vs #Parkinsons & controls.
Tweet media one
1
0
10
@ScienceofPD
The Science of Parkinson's
12 days
New research from @Angelika_Za @rimonaweil & colleagues finds impaired glymphatic clearance (measured using diffusion tensor image analysis along the perivascular space) is linked to poor cognitive outcomes in #Parkinsons.
Tweet media one
Tweet media two
Tweet media three
0
0
2
@ScienceofPD
The Science of Parkinson's
12 days
New research from @SamuelStupp & colleagues presents a bioactive supramolecular nanostructure containing a peptide designed based on glial cell-derived neurotrophic factor (GDNF); In vitro & in vivo data support utility in cell therapy for #Parkinsons.
Tweet media one
Tweet media two
Tweet media three
0
0
0
@ScienceofPD
The Science of Parkinson's
12 days
Researchers report that early Locus Coeruleus noradrenergic axon loss coincides with impaired olfaction in an #Alzheimers mouse model; They also find similar results in postmortem & TSPO-PET analyses in prodromal AD patients olfactory bulb .
Tweet media one
Tweet media two
Tweet media three
0
0
1
@ScienceofPD
The Science of Parkinson's
12 days
New research reports that an iPad-based eye movement assessment system meets or exceeds the benchmarks set by a clinical-grade eye tracker (EyeLink 1000 Plus), supporting its use as a scalable & cost-effective tool for screening & monitoring #Parkinsons.
Tweet media one
0
0
0
@ScienceofPD
The Science of Parkinson's
12 days
New research finds that membrane packing defects are necessary for N-terminally acetylated-αSynuclein binding & that defect-rich membranes are sufficient for NTA-αSyn binding regardless of membrane charge.
Tweet media one
0
0
3
@ScienceofPD
The Science of Parkinson's
13 days
Interestingly, "PPARGC1A (PGC-1α), GPX4, NFE2L2 (NRF2), & SIRT3 decreased with increasing disease burden, while only SIRT1 expression increased, reflecting oxidative stress & mitochondrial dysregulation. Overall, the PD monocyte transcripts correlated with PD disease burden".
0
0
1
@ScienceofPD
The Science of Parkinson's
13 days
Prof Stanley Appel (92 years old & still researching!) & @MethodistHosp colleagues report peripheral monocyte transcriptional signatures from 62 people with #Parkinsons; After H&Y stratification, inflam. transcripts (IL-6, IL-1β, etc) were⬆️in PD monocytes.
Tweet media one
Tweet media two
Tweet media three
1
0
1
@ScienceofPD
The Science of Parkinson's
13 days
Using data from 167 studies, a new systematic review of risk factors & predictors for Lewy body dementia reports factors like older age, ♂️, APOEe4, GBA, changes in cognition, mood, behavior, sleep, gait/posture, speech, parkinsonism, & smell loss.
Tweet media one
0
0
2
@ScienceofPD
The Science of Parkinson's
13 days
An exploratory mixed methods feasibility study deems a modified, low dairy ketogenic diet feasible and acceptable for people with #Parkinsons (small study, 12 people, 12 weeks; Needs to be replicated).
Tweet media one
Tweet media two
Tweet media three
0
0
1